Comparison of serum cytokine concentrations between healthy dogs and canine osteosarcoma patients at the time of diagnosis
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 227, 110084
Abstract
No abstract availableKeywords
Funding Information
- Oregon State University
This publication has 29 references indexed in Scilit:
- Association of Interleukin-12 Polymorphisms and Serum IL-12p40 Levels with Osteosarcoma RiskDNA and Cell Biology, 2013
- Effect of the cytokine levels in serum on osteosarcomaTumor Biology, 2013
- Performance of Multiplex Cytokine Assays in Serum and Saliva among Community-Dwelling Postmenopausal WomenPLOS ONE, 2013
- IL-12 and IL-27 Sequential Gene Therapy via Intramuscular Electroporation Delivery for Eliminating Distal Aggressive TumorsThe Journal of Immunology, 2010
- Chronic bacterial osteomyelitis suppression of tumor growth requires innate immune responsesCancer Immunology, Immunotherapy, 2009
- Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985–2004)Journal of the American Veterinary Medical Association, 2006
- Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: Correlations with local tumor extent and prognosisJournal of Surgical Oncology, 2003
- Cytokine serum levels in soft tissue sarcoma patients: Correlations with clinico‐pathological features and prognosisInternational Journal of Cancer, 2002
- Interleukin‐8, a chemotactic and inflammatory cytokineFEBS Letters, 1992
- Neutrophil Attractant/Activation Protein-1 (NAP-1 [Interleukin-8])American Journal of Respiratory Cell and Molecular Biology, 1990